173 related articles for article (PubMed ID: 29900011)
1. Adjuvant composition and delivery route shape immune response quality and protective efficacy of a recombinant vaccine for
Abhyankar MM; Orr MT; Lin S; Suraju MO; Simpson A; Blust M; Pham T; Guderian JA; Tomai MA; Elvecrog J; Pedersen K; Petri WA; Fox CB
NPJ Vaccines; 2018; 3():22. PubMed ID: 29900011
[TBL] [Abstract][Full Text] [Related]
2. Optimizing a Multi-Component Intranasal
Abhyankar MM; Orr MT; Kinsey R; Sivananthan S; Nafziger AJ; Oakland DN; Young MK; Farr L; Uddin MJ; Leslie JL; Burgess SL; Liang H; De Lima I; Larson E; Guderian JA; Lin S; Kahn A; Ghosh P; Reed S; Tomai MA; Pedersen K; Petri WA; Fox CB
Front Immunol; 2021; 12():683157. PubMed ID: 34248966
[TBL] [Abstract][Full Text] [Related]
3. Nanoformulation of synergistic TLR ligands to enhance vaccination against Entamoeba histolytica.
Abhyankar MM; Noor Z; Tomai MA; Elvecrog J; Fox CB; Petri WA
Vaccine; 2017 Feb; 35(6):916-922. PubMed ID: 28089548
[TBL] [Abstract][Full Text] [Related]
4. Intranasal delivery of a synthetic Entamoeba histolytica vaccine containing adjuvant (LecA + GLA-3 M-052 liposomes): In vitro characterization.
Murphy BM; Chen JZ; Rolo M; Eldam M; Jordan L; Sivananthan SJ; Kinsey R; Guderian JA; Pedersen K; Abhyankar M; Petri WA; Fox CB; Finlay WH; Vehring R; Martin AR
Int J Pharm; 2022 Oct; 626():122141. PubMed ID: 36058408
[TBL] [Abstract][Full Text] [Related]
5. Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon.
Guo X; Barroso L; Becker SM; Lyerly DM; Vedvick TS; Reed SG; Petri WA; Houpt ER
Infect Immun; 2009 Sep; 77(9):3909-18. PubMed ID: 19564375
[TBL] [Abstract][Full Text] [Related]
6. A nanoliposome delivery system to synergistically trigger TLR4 AND TLR7.
Fox CB; Sivananthan SJ; Duthie MS; Vergara J; Guderian JA; Moon E; Coblentz D; Reed SG; Carter D
J Nanobiotechnology; 2014 Apr; 12():17. PubMed ID: 24766820
[TBL] [Abstract][Full Text] [Related]
7. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis.
Orr MT; Fox CB; Baldwin SL; Sivananthan SJ; Lucas E; Lin S; Phan T; Moon JJ; Vedvick TS; Reed SG; Coler RN
J Control Release; 2013 Nov; 172(1):190-200. PubMed ID: 23933525
[TBL] [Abstract][Full Text] [Related]
9. Attachment of class B CpG ODN onto DOTAP/DC-chol liposome in nasal vaccine formulations augments antigen-specific immune responses in mice.
Tada R; Muto S; Iwata T; Hidaka A; Kiyono H; Kunisawa J; Aramaki Y
BMC Res Notes; 2017 Jan; 10(1):68. PubMed ID: 28126014
[TBL] [Abstract][Full Text] [Related]
10. Adherence-inhibitory intestinal immunoglobulin a antibody response in baboons elicited by use of a synthetic intranasal lectin-based amebiasis subunit vaccine.
Abd Alla MD; White GL; Rogers TB; Cary ME; Carey DW; Ravdin JI
Infect Immun; 2007 Aug; 75(8):3812-22. PubMed ID: 17526742
[TBL] [Abstract][Full Text] [Related]
11. A lipidic delivery system of a triple vaccine adjuvant enhances mucosal immunity following nasal administration in mice.
Wasan EK; Syeda J; Strom S; Cawthray J; Hancock RE; Wasan KM; Gerdts V
Vaccine; 2019 Mar; 37(11):1503-1515. PubMed ID: 30739796
[TBL] [Abstract][Full Text] [Related]
12. Synthetic Toll-like receptor 4 (TLR4) and TLR7 ligands as influenza virus vaccine adjuvants induce rapid, sustained, and broadly protective responses.
Goff PH; Hayashi T; Martínez-Gil L; Corr M; Crain B; Yao S; Cottam HB; Chan M; Ramos I; Eggink D; Heshmati M; Krammer F; Messer K; Pu M; Fernandez-Sesma A; Palese P; Carson DA
J Virol; 2015 Mar; 89(6):3221-35. PubMed ID: 25568203
[TBL] [Abstract][Full Text] [Related]
13. Liposomal nanoparticle-based conserved peptide influenza vaccine and monosodium urate crystal adjuvant elicit protective immune response in pigs.
Dhakal S; Cheng X; Salcido J; Renu S; Bondra K; Lakshmanappa YS; Misch C; Ghimire S; Feliciano-Ruiz N; Hogshead B; Krakowka S; Carson K; McDonough J; Lee CW; Renukaradhya GJ
Int J Nanomedicine; 2018; 13():6699-6715. PubMed ID: 30425484
[TBL] [Abstract][Full Text] [Related]
14. Glucopyranosyl Lipid Adjuvant (GLA), a Synthetic TLR4 agonist, promotes potent systemic and mucosal responses to intranasal immunization with HIVgp140.
Arias MA; Van Roey GA; Tregoning JS; Moutaftsi M; Coler RN; Windish HP; Reed SG; Carter D; Shattock RJ
PLoS One; 2012; 7(7):e41144. PubMed ID: 22829921
[TBL] [Abstract][Full Text] [Related]
15. Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB.
Verma V; Tan W; Puth S; Cho KO; Lee SE; Rhee JH
J Transl Med; 2016 May; 14(1):135. PubMed ID: 27184355
[TBL] [Abstract][Full Text] [Related]
16. Use of protective antigen of Bacillus anthracis as a model recombinant antigen to evaluate toll-like receptors 2, 3, 4, 7 and 9 agonists in mice using established functional antibody assays, antigen-specific antibody assays and cellular assays.
Inglefield J; Catania J; Harris A; Hickey T; Ma Z; Minang J; Baranji K; Spangler T; Look J; Ruiz C; Lu H; Alleva D; Reece JJ; Lacy MJ
Vaccine; 2022 Sep; 40(38):5544-5555. PubMed ID: 35773119
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant activity of monophosphoryl lipid A for nasal and oral immunization with soluble or liposome-associated antigen.
Childers NK; Miller KL; Tong G; Llarena JC; Greenway T; Ulrich JT; Michalek SM
Infect Immun; 2000 Oct; 68(10):5509-16. PubMed ID: 10992447
[TBL] [Abstract][Full Text] [Related]
18. Prevention of intestinal amebiasis by vaccination with the Entamoeba histolytica Gal/GalNac lectin.
Houpt E; Barroso L; Lockhart L; Wright R; Cramer C; Lyerly D; Petri WA
Vaccine; 2004 Jan; 22(5-6):611-7. PubMed ID: 14741152
[TBL] [Abstract][Full Text] [Related]
19. TLR4 ligand formulation causes distinct effects on antigen-specific cell-mediated and humoral immune responses.
Fox CB; Moutaftsi M; Vergara J; Desbien AL; Nana GI; Vedvick TS; Coler RN; Reed SG
Vaccine; 2013 Dec; 31(49):5848-55. PubMed ID: 24120675
[TBL] [Abstract][Full Text] [Related]
20. Protective efficacy of intranasal inactivated pseudorabies vaccine is improved by combination adjuvant in mice.
Hua T; Chang C; Zhang X; Huang Y; Wang H; Zhang D; Tang B
Front Microbiol; 2022; 13():976220. PubMed ID: 36187997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
